Treatment of Intrabony Defect in Patient With Periodontitis Stage III by Using I-PRF and Xenograft
Injectable Platelet Rich Fibrin (I-PRF) With Xenograft in Intrabony Defects of Periodontitis Patient Stage III Versus Xenograft Alone
Injectable Platelet Rich Fibrin (I-PRF) With Xenograft in Intrabony Defects of Periodontitis Patient Stage III Versus Xenograft Alone
Sponsor study identifier
interventional
20
1 country
2
Study Start
February 17, 2025
Actual (reported)Primary Completion
February 18, 2025
Actual (reported)Study Completion
December 17, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Evaluate of the injectable platelet rich fibrin (I-PRF) with xenograft in Intrabony defects of Periodontitis patient stage III versus Xenograft alone.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 17, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 17, 2025
Actual (reported)February 18, 2025
Actual (reported)August 21, 2025
Actual (reported)December 3, 2025
Actual (reported)December 17, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Radiographic parameters
• The bone fill after 6 months postoperatively using digital periapical radiography using parallel technique.
6 months after treatment
Pocket depth (PD)
presurgically, 3 and 6 months interval after treatment
Plaque index (PI)
pre-surgically 3 months and 6 months respectively
Gingival index (GI)
pre-surgically 3 months and 6 months respectively
Clinical attachment level (CAL)
pre-surgically 3 months and 6 months respectively
Intrasulcular incisions will be performed buccally and lingually/palatally on the affected tooth and extended one adjacent tooth mesially and distally, using 15c blades. Following mucoperiosteal flap elevation, thorough debridement will be performed using ultrasonic scalers and curettes until defects are clear from any granulation tissue, and the defect morphology will be visually explored and recorded .In the group 2: xenograft (Bovin xenograft) with injectable platelet Rich fibrin (I- PRF) will be applied to the intrabony defect area.
Intrasulcular incisions will be performed buccally and lingually/palatally on the affected tooth and extended one adjacent tooth mesially and distally, using 15c blades. Following mucoperiosteal flap elevation, thorough debridement will be performed using ultrasonic scalers and curettes until defects are clear from any granulation tissue, and the defect morphology will be visually explored and recorded, inserting the xenograft to the defect
Elevation of papilla preservation flap at the site of 3mm infrabony defect ,prepearing the I-PRF which is obtained from the patients own blood , centrifuged at 700 rpm in 3 min and mixed with xenograft than placed at the defect area after removal all the granulation tissue follow up after 3 and 6 months intervals
Faculty of Dental Medicine for Girls, Al- Azhar University
Cairo, Cairo Governorate, Egypt
Ola Jamal
Cairo, Cairo Governorate, Egypt
Eatemad Ahmed Shoreibah A Shoreibah, Professor
Al-Azhar University
First Submitted
August 21, 2025
First Posted
December 3, 2025
Study Start
February 17, 2025
Actual (reported)Primary Completion
February 18, 2025
Elevation of papilla preservation flap at the site of 3mm infrabony defect after removal all the granulation tissue, the xenograft alone inserted to the defect, suturing and follow up after 3 and 6 months intervals
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Study Completion
December 17, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
December 3, 2025
Record last verified: 2025-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: